Literature DB >> 12208943

Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay.

Diane Sitki-Green1, Rachel H Edwards, Jennifer Webster-Cyriaque, Nancy Raab-Traub.   

Abstract

Epstein-Barr virus (EBV) strains can be distinguished by specific sequence variations in the LMP1 gene. In this study, a heteroduplex tracking assay (HTA) specific for LMP1 was developed to precisely identify the prototypic undeleted strain B958, other undeleted strains (Ch2, AL, NC, and Med-), and strains with the 30-bp deletion (Med+ and Ch1). This technique also provides an estimate of the relative abundance of strains in patient samples. In this study, EBV strains were identified in 25 hairy leukoplakia (HLP) biopsies and six matched peripheral blood samples and throat washes with the LMP1-HTA. To investigate the relationship of the virus found in the peripheral blood to that in the HLP lesion, the strain variants in the peripheral blood B lymphocytes and those present within the epithelial cells in the HLP lesion and in throat washes were identified. In many of the subjects, compartmental differences in the EBV strain profiles in the oral cavity and peripheral blood were readily apparent. The throat wash specimens usually had a strain profile similar to that within the corresponding HLP sample, which was distinct from the strain profile detected in the peripheral blood. These analyses reveal that the nature of EBV infection can be very dynamic, with changes in relative strain abundance over time as well as the appearance of new strains. The patterns of abundance in the blood and oral cavity provide evidence for compartmentalization and for the transmission of strains between the blood and oropharynx.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208943      PMCID: PMC136523          DOI: 10.1128/jvi.76.19.9645-9656.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay.

Authors:  J A Nelson; S A Fiscus; R Swanstrom
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates.

Authors:  K Sandvej; J W Gratama; M Munch; X G Zhou; R L Bolhuis; B S Andresen; N Gregersen; S Hamilton-Dutoit
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

3.  Sequence variation of latent membrane protein-1 of Epstein-Barr virus strains associated with hairy leukoplakia.

Authors:  J M Palefsky; J Berline; M E Penaranda; E T Lennette; D Greenspan; J S Greenspan
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

4.  Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses.

Authors:  S A Freel; J M Williams; J A Nelson; L L Patton; S A Fiscus; R Swanstrom; D C Shugars
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals.

Authors:  Q Y Yao; R J Tierney; D Croom-Carter; G M Cooper; C J Ellis; M Rowe; A B Rickinson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different Epstein-Barr virus strains.

Authors:  S Henry; C Sacaze; L Berrajah; H Karray; M Drira; A Hammami; J Icart; B Mariame
Journal:  Int J Cancer       Date:  2001-03-01       Impact factor: 7.396

7.  Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells.

Authors:  G Niedobitek; A Agathanggelou; N Steven; L S Young
Journal:  Mol Pathol       Date:  2000-02

8.  Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis, and clinical significance.

Authors:  D Triantos; S R Porter; C Scully; C G Teo
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

9.  Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas.

Authors:  K Bhatia; A Raj; M I Guitierrez; J G Judde; G Spangler; H Venkatesh; I T Magrath
Journal:  Oncogene       Date:  1996-07-04       Impact factor: 9.867

10.  A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.

Authors:  W Resch; N Parkin; E L Stuelke; T Watkins; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  15 in total

1.  LMP1 strain variants: biological and molecular properties.

Authors:  Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.

Authors:  Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras
Journal:  J Biol Chem       Date:  2014-04-23       Impact factor: 5.157

3.  Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1.

Authors:  Talita Ribeiro Tenório de França; Alessandra de Albuquerque Tavares Carvalho; Valder Barbosa Gomes; Luiz Alcino Gueiros; Stephen Ross Porter; Jair Carneiro Leao
Journal:  Clin Oral Investig       Date:  2011-03-29       Impact factor: 3.573

4.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.

Authors:  Nicholas Renzette; Mohan Somasundaran; Frank Brewster; James Coderre; Eric R Weiss; Margaret McManus; Thomas Greenough; Barbara Tabak; Manuel Garber; Timothy F Kowalik; Katherine Luzuriaga
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

6.  Multiple Epstein-Barr virus infections in healthy individuals.

Authors:  Dennis M Walling; Abigail L Brown; Wiguins Etienne; Wendy A Keitel; Paul D Ling
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 7.  Oral manifestations associated with HIV infection.

Authors:  Mostafa Nokta
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

8.  Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers.

Authors:  Diane Sitki-Green; Mary Covington; Nancy Raab-Traub
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Potential selection of LMP1 variants in nasopharyngeal carcinoma.

Authors:  Rachel H Edwards; Diane Sitki-Green; Dominic T Moore; Nancy Raab-Traub
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Herpesviruses in abscesses and cellulitis of endodontic origin.

Authors:  Vicky Chen; Yanwen Chen; Hong Li; Karla Kent; J Craig Baumgartner; Curtis A Machida
Journal:  J Endod       Date:  2009-02       Impact factor: 4.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.